Scholar Rock Holding Corporation has appointed Rebecca McLeod as Chief Brand Officer and U.S. General Manager. McLeod, a 25-year industry veteran, will lead the U.S. commercial launch of apitegromab for spinal muscular atrophy $(SMA)$ and establish its global brand strategy. Previously, she was responsible for the U.S. launch of VYVGART® at argenx.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scholar Rock Holding Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20250602531955) on June 02, 2025, and is solely responsible for the information contained therein.